abstract |
The invention is concerned with novel pyrazol derivatives of formula (I), n nwhereinn n nR 1 , R 2 , R 3 , R 4 , X and Y are as defined herein, as well as physiologically acceptable salts thereof. These compounds are antagonists of CCR-2 receptor and/or CCR-5 receptor and can be used as medicaments. |